FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372488002: Dolasetron (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197781015 Dolasetron (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211023010 Dolasetron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
38741000188117 dolasétron fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolasetron (substance) Is a 5-HT3 receptor antagonist true Inferred relationship Some
Dolasetron (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. 5-HT3 receptor antagonist true Inferred relationship Some
Dolasetron (substance) Is a allergène médicamenteux false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Dolasetron mesilate Is a False Dolasetron (substance) Inferred relationship Some
Product containing dolasetron (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Some 1
Dolasetron mesilate 20 mg powder for solution for injection ampoule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Some
Dolasetron mesylate monohydr 50mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Some
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Some
Dolasetron mesylate monohydr 100mg/5 mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Some
Dolasetron mesilate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Some
Dolasetron mesilate 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Some
Dolasetron mesilate 20mg/mL injection solution 0.625mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Some
Dolasetron mesilate 20mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Some
Product containing dolasetron in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Some 1
Dolasetron-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Some 1
Dolasetron mesilate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Dolasetron (substance) Inferred relationship Some
Product containing only dolasetron (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Some 1
Dolasetron only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Some 1
Dolasetron only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start